Soren Emerson


Vanderbilt University

Soren Emerson is a an entering first year PhD student in the Vanderbilt University neuroscience program. He previously attended, and graduated from, Davidson College with a B.S. in neuroscience. He conducted three years of independent research at Davidson College under the mentorship of Dr. Mark Smith, a behavioral pharmacologist, and Dr. Rachid El Bejjani, a C. elegans neurobiologist. His research modeled the genetic and molecular mechanism of cocaine in C. elegans and the results of the project yielded a first author publication. At Vanderbilt, Soren plans to continue his research career in neuropharmacology.

Soren has authored 1 article

A new drug reduces risk of psychosis relapse in patients with dementia

Read now →

Pimavanserin has not received approval from the FDA, but study results are encouraging

Soren Emerson

Soren has shared 8 notes

Psilocybin reduced depression symptoms as much as a leading antidepressant

Read now →

New research compared the "magic mushrooms" component to Lexapro

Tapering off opioids is treacherous for mental health

Read now →

A large-scale study shows how the opioid epidemic has created downstream negative health outcomes

New machine learning approach can identify your circadian rhythm from a blood sample

Read now →

Doctors do not currently monitor a person's circadian rhythms because there is not an efficient way to measure them

Drinking way, way too much coffee might shrink your brain

Read now →

Up to five cups of coffee per day seems to be fine. Six or more? Your brain is going to feel it

What nematodes laying eggs tells us about how cocaine affects the brain

Read now →

New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction

Drug overdose deaths in the US jumped nearly 30 percent in 2020

Read now →

The story behind these numbers is complex, but opioids have played a major role

Modified tree resins prevent zebrafish from having seizures

Read now →

Could these resins also be used to treat epilepsy in humans?

Laughing gas could be the next tool against treatment-resistant depression

Read now →

A small clinical trial shows promise for people who don't find relief from antidepressants

Soren has left Comment 4 peer comments

Could blockchain technology protect patients from counterfeit medication?

Read now →

Not so fast. We should be wary of trying to science our way out of large-scale health issues

Simon Spichak

Comment 2 peer comments

New drug addresses long overlooked "negative" symptoms of schizophrenia

Read now →

A data-driven search found a compound that shows promising results in early trials

Elizabeth Burnette

Comment 3 peer comments

We must reckon with our ableism if we want healthcare to work for people

Read now →

People who had COVID-19 may need long-term care — the US healthcare system isn't ready

Olivia Bernard

Comment 6 peer comments

The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory

Read now →

To explain where SARS-CoV-2 came from, look at processes with scientific explanations and precedents

Dan Samorodnitsky

Comment 5 peer comments